Hampus Hillerstrom
Overview
Explore the profile of Hampus Hillerstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hillerstrom H, Fisher R, Janicki M, Chicoine B, Christian B, Esbensen A, et al.
Alzheimers Dement
. 2024 Mar;
20(5):3649-3656.
PMID: 38480678
Prior authorization criteria for Federal Drug Administration (FDA) approved immunotherapeutics, among the class of anti-amyloid monoclonal antibodies (mAbs), established by state drug formulary committees, are tailored for adults with late-onset...
2.
Rubenstein E, Kyprianou N, Sujin Kumar P, Kriova A, Sokoloff A, Hillerstrom H, et al.
Am J Intellect Dev Disabil
. 2023 Jul;
128(4):273-281.
PMID: 37470258
Individuals with Down syndrome (DS) have been disproportionately harmed by the COVID-19 pandemic and may have been more likely to have sacrificed opportunity and activity to avoid potential exposures. Our...
3.
De La Garza E, Scott A, Hillerstrom H, Hendrix J, Rubenstein E
Am J Med Genet C Semin Med Genet
. 2023 Apr;
196(1):e32041.
PMID: 37072379
Research regarding caregivers for individuals with Down syndrome mainly focuses on outcomes for the pediatric population and not on the experience of caregivers themselves. Our objective was to understand caregiver-reported...
4.
White A, Chevette M, Hillerstrom H, Esbensen A
J Appl Res Intellect Disabil
. 2021 Sep;
35(1):179-187.
PMID: 34510659
Background: Down syndrome is the most common genetic disorder associated with intellectual and developmental disabilities. Research to improve health care outcomes in Down syndrome lags significantly behind other disease categories....
5.
Hendrix J, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson H, et al.
Transl Sci Rare Dis
. 2021 Jul;
5(3-4):99-129.
PMID: 34268067
Background: Recent advances in medical care have increased life expectancy and improved the quality of life for people with Down syndrome (DS). These advances are the result of both pre-clinical...
6.
Hendrix J, Airey D, Britton A, Burke A, Capone G, Chavez R, et al.
J Clin Med
. 2021 Apr;
10(9).
PMID: 33924960
With improved healthcare, the Down syndrome (DS) population is both growing and aging rapidly. However, with longevity comes a very high risk of Alzheimer's disease (AD). The LIFE-DSR study (NCT04149197)...
7.
Knox K, Stanley J, Hendrix J, Hillerstrom H, Dunn T, Achenbach J, et al.
J Patient Rep Outcomes
. 2021 Jan;
5(1):5.
PMID: 33427993
Background: As life expectancy of people with Down syndrome (DS) increases, so does the risk of Alzheimer's disease (AD). Identifying symptoms and tracking disease progression is especially challenging whenever levels...